ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JAPHET GAZTAMBIDE M.D.

CENTRO DE SALUD CONDUCTUAL DE AGUADILLA AVE. KENNEDY # 15

Aguadilla | Puerto Rico | 00603

(787) 840-2575

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,350Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 190

$1.54M Total Retail Price of All Prescriptions

Rank: 1 out of 190

1,543 Patients Receiving at Least One Drug in Part D
22%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

12% of this provider’s 4,040 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
CITALOPRAM HBR 2,106 527 10 1 6
FLUOXETINE HCL 1,738 323 10 2 1
SERTRALINE HCL 1,424 398 3 3
RISPERIDONE 1,233 192 4 5
PAROXETINE HCL 1,193 212 10 5 4
BUPROPION XL 1,074 65 10 6 8
DIVALPROEX SODIUM 923 45 7 14
DOXEPIN HCL 877 139 10 8 12
QUETIAPINE FUMARATE 863 166 9 9
TRAZODONE HCL 708 123 10 7
ABILIFY 651 91 11 18
ZOLPIDEM TARTRATE 597 96 12 2
AMITRIPTYLINE HCL 547 135 R 13 11
TRIFLUOPERAZINE HCL 542 91 10 14 30
VENLAFAXINE HCL ER 532 75 15 13
HYDROXYZINE PAMOATE 496 69 R 10 16 23
SEROQUEL 473 89 17 22
DIPHENHYDRAMINE HCL 458 99 R 10 18 20
BENZTROPINE MESYLATE 398 93 R 19 15
OLANZAPINE 380 79 20 19
CYMBALTA 365 0 21 10
BUPROPION HCL SR 332 40 22 17
THIORIDAZINE HCL 293 66 R 10 23 35
HALOPERIDOL 255 61 24 21
SEROQUEL XR 248 62 25 34
RANITIDINE HCL 208 37 26 37
BUDEPRION XL 178 15 10 27 44
DIVALPROEX SODIUM ER 167 11 28 31
IMIPRAMINE HCL 165 39 R 29 49
THIOTHIXENE 165 36 29 41
LITHIUM CARBONATE 158 16 31 27
ESCITALOPRAM OXALATE 153 29 32 33
BUSPIRONE HCL 148 11 33 16
CHLORPROMAZINE HCL 129 25 34 26
GABAPENTIN 124 22 35 38
DONEPEZIL HCL 121 78 36 29
NORTRIPTYLINE HCL 118 26 37 42
ZIPRASIDONE HCL 115 0 38 45
CLONAZEPAM 95 23 39 28
OMEPRAZOLE 92 18 40 43
PERPHENAZINE 91 19 41 39
MIRTAZAPINE 74 0 42 25
BUDEPRION SR 64 0 10 43 52
LEXAPRO 62 28 44 60
GEODON 60 0 45 62
HALOPERIDOL DECANOATE 54 31 46 55
FLUPHENAZINE DECANOATE 50 11 47 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.